UNSPSC 51382702: Sulindac

This classification denotes a cyclooxygenase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 184SNS8VUH. European Medicines Agency schedules Sulindac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10744MIG. Sulindac generally arises in the molecular formula C20H17FO3S.

UNSPSC 51382702 Sulindac, a Commodity code, nominally covers a nonsteroidal anti-inflammatory drug; however, the recent state and local solicitation activity under this code does not reflect pharmaceutical procurement in line with the code's name. Seminole County, Florida posted an IFB in June 2026 for naloxone and drug deactivation systems — opioid-reversal medication and harm-reduction equipment — which falls outside the sulindac drug category and signals a potential classification mismatch in the county's procurement tagging. The code shows little relevant recent activity aligned with its nominal scope. State and local governments purchasing under pharmaceutical commodity codes typically procure through cooperative purchasing vehicles, group purchasing organizations, or standing contracts with pharmaceutical distributors, often with volume discounts and compliance requirements tied to formulary approvals and controlled-substance regulations.

Seminole County, Florida represents the only identifiable recent activity in the opportunities block. The IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems for annual delivery to the Seminole County Community Health Building in Sanford, Florida on a quarterly basis. The contract included a two-year initial term with one-year renewal option, drug-free workplace and E-Verify compliance requirements, standard commercial insurance coverage, and potential FEMA funding with corresponding federal environmental compliance obligations. Given the code's limited recent procurement signal and the apparent classification mismatch in the Seminole County record, the code warrants monitoring rather than active pursuit until clearer sulindac-specific procurement patterns emerge in state and local markets.